Jasper Therapeutics share price logo

Jasper Therapeutics

NASDAQ: JSPR

$0.66

-0.04

(-5.81%)

as on

Jasper Therapeutics Stock Performance

as on September 12, 2026 at 6:59 am IST

  • Day's High

    $0.66
    $0.71

    7.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.32
    $2.69
    downward going graph

    52.26%

    Downside

    307.58%

    Upside

    downward going graph

Jasper Therapeutics share price movements today

Previous Close
$0.70
Open
$0.70
Volume
759.0K
Market Cap
$23.6M
Day's Low - High
$0.66 - $0.71
52 Week Low - High
$0.32 - $2.69

Jasper Therapeutics Historical Returns

1 Month Return
-12.31 %
3 Month Return
+ 50.98 %
1 Year Return
-72.83 %
3 Year Return
-92.38 %
5 Year Return
0 %

Jasper Therapeutics Stock Fundamentals & Key Indicators

Check Jasper Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.6M

EPS (TTM)

-1.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.44

Industry PE ratio

-1.62

PEG Ratio

-0.0030795354702717486

EBITDA

-31.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-618.87%

Jasper Therapeutics Stock Valuation

Track how Jasper Therapeutics P/E has moved over time to understand its valuation trends.

Jasper Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-4.37x)

December 31, 2024

Industry (-1.62x)

December 31, 2025

Today (-0.46x)

December 31, 2025

Highest (-0.46x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.46x

Jasper Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jasper Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$23.6MNA-0.440.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for Jasper Therapeutics Stock including INR - Dollar returns

The Jasper Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Jasper Therapeutics investment value today

Current value as on today

₹27,689

Returns

-₹72,311

(-72.31%)

Returns from Jasper Therapeutics Stock

-₹74,419 (-74.42%)

Dollar Impact

₹2,108 (+2.11%)

Analyst Recommendation on Jasper Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Jasper Therapeutics. Average target price of $7.38

Jasper Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Jasper Therapeutics.

What analysts predicted

91.06%UPSIDE

Target Price

$7.38

Current Price

$0.66

Analyzed by

2 Analysts

Target

$7.38

Jasper Therapeutics target price $7.38, a slight upside of 91.06% compared to current price of $0.66. According to 2 analysts rating.

Indian Investors' Interest in Jasper Therapeutics Stock

Search interest for Jasper Therapeutics Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Jasper Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
-
0
-
Operating Income
-15
-15
-19
-25
-21
-27
-19
-15
-10
-9
EBITDA
-13
-14
-18
-24
-20
-26
-18
-8
-1
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-13
-14
-18
-24
-21
-26
-18
-9
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-13
-14
-18
-24
-21
-26
-18
-9
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Jasper Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-1
Operating Income
-4
-20
-36
-51
-68
-76
-80
EBITDA
-
-
-30
-36
-63
-69
-74
Interest Expense
-
-
-
-
-
-
-
Depreciation
4
20
0
0
1
1
1
Income Before Tax
-4
-31
-30
-37
-64
-71
-75
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-4
-31
-30
-37
-64
-71
-75
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Jasper Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-14
-18
-24
-21
-26
-18
-9
-1
-2
Operating Cash Flow
-15
-11
-14
-21
-22
-15
-16
-21
-14
-6
Investing Cash Flow
0
0
0
0
0
0
-
-
-
0
Financing Cash Flow
47
0
0
0
-
6
28
0
-
0
Change in Cash
31
-11
-14
-20
-22
-9
11
-22
-14
-6

Jasper Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-31
-30
-37
-64
-71
-75
Operating Cash Flow
-1
-18
-33
-45
-52
-62
-77
Investing Cash Flow
-
-
-2
0
0
0
0
Financing Cash Flow
29
11
100
0
100
47
34
Change in Cash
27
-6
64
-46
48
-15
-42

Mutual Funds that own Jasper Therapeutics Stock

Check out the Mutual Funds with significant holdings in Jasper Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.442338%
1145423
Fidelity Concord Street Trust
0.695621%
231465
VANGUARD VALLEY FORGE FUNDS
0.081665%
27174
MUTUAL FUND SERIES TRUST
0.052592%
17500
Victory Portfolios III
0.027973%
9308

Global Institutional Holdings in Jasper Therapeutics

Funds
Holdings
Vanguard
3.44%
Michael Rockefeller
3.13%
Mark Diker
0.11%

Jasper Therapeutics News & Key Events

  • img

    Today's Timeline - 15 November

    Sun, 07:41 AM

    -

    Rosen Law Firm reminds Jasper investors of November 18 deadline for securities class action regarding misleading statements.

    Sat, 05:56 PM

    -

    Faruqi & Faruqi investigates claims against Jasper, highlighting misleading statements and upcoming lead plaintiff deadline.

Insights on Jasper Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 438.1% return, outperforming this stock by 510.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 29.1% return, outperforming this stock by 120.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, JSPR stock has moved down by -21.5%

About Jasper Therapeutics

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
OrganisationJasper Therapeutics
Headquarters2200 Bridge Pkwy, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEOMr. Jeetinder Singh Mahal M.B.A.
E-voting on sharesClick here to vote

Key Management of Jasper Therapeutics

Name

Title

Mr. Jeetinder Singh Mahal M.B.A.

President, CEO & Director

Mr. Herbert C. Cross CPA

CFO & Corporate Secretary

Mr. Matthew E. Ros

Chief Operating Officer

Alex Gray

Head of Investor Relations

Mr. Thomas G. Wiggans

Executive Chairman

Dr. Judith Anne Shizuru M.D., Ph.D.

Co-Founder, Member of Scientific Advisory Board & Director

Mr. Matthew Ford

Senior Vice President of Human Resources

Dr. Gregory F. Keenan M.D.

Chief Medical Officer

Dr. Wenru Song M.D., Ph.D.

Executive VP and Head of R&D

FAQs

What is Jasper Therapeutics share price today?

Jasper Therapeutics share price today is $0.66 as on at the close of the market. Jasper Therapeutics share today touched a day high of $0.71 and a low of $0.66.

What is the 52 week high and 52 week low for Jasper Therapeutics share?

Jasper Therapeutics share touched a 52 week high of $2.69 on and a 52 week low of $0.32 on . Jasper Therapeutics stock price today i.e. is closed at $0.66,which is 75.46% down from its 52 week high and 109.46% up from its 52 week low.

What is Jasper Therapeutics's market capitalisation today?

Jasper Therapeutics market capitalisation is $0.00T as on .

How to invest in Jasper Therapeutics Stock (JSPR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jasper Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jasper Therapeutics Shares that will get you 2.2727 shares as per Jasper Therapeutics share price of $0.66 per share as on September 12, 2026 at 1:29 am IST.

What is the minimum amount required to buy Jasper Therapeutics Stock (JSPR) from India?

Indian investors can start investing in Jasper Therapeutics (JSPR) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Jasper Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Jasper Therapeutics share’s latest price of $0.66 as on September 12, 2026 at 1:29 am IST, you will get 15.1515 shares of Jasper Therapeutics. Learn more about fractional shares .